Inter-reader variability can create challenges in oncology trial results. During this 45-minute presentation, Median Technologies addresses the 4 main causes of variability occurring during RECIST1.1 assessment and describes control strategies using data analytics and medical investigations. During this presentation, you will:
- Discover the most common types of reader discrepancies in oncology follow-up
- Learn how to control the causes of variability in centralized independent review and how to prevent them
- Grasp how we at Median Technologies, handle inter-reader variability through our methods and strategies
Presenters
- Antoine Iannessi, Medical Director, Median Technologies
- Emilie Serres, Clinical Research Scientist, Median Technologies